GLP-1 Clinical Relevance #42Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational Study DesignSubstance Use DisorderGLP-1 Receptor AgonistAddiction MedicineAdults with ObesityBehavioral Outcome ModificationDopamine Pathway ModulationCannabis...
GLP-1 Weight Loss Drugs: Semaglutide and Tirzepatide Evidence
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational Study DesignWeight Loss ManagementSemaglutideEndocrinology and Primary CareAdults with ObesitySustainable Weight ReductionAppetite Regulation and...
GLP-1 Weight Loss: Clinical Evidence and Safety
GLP-1 Clinical Relevance #33Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical Case ReportObservational Study DesignWeight Loss Drug Adverse EffectsGLP-1 Receptor AgonistEndocrinologyYoung Adults with ObesityAdverse Event...
GLP-1 Receptor Agonist Randomized Trial Data
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational Study DesignPancreatitis RiskSemaglutideEndocrinologyAdults with Type 2 DiabetesAdverse Event MonitoringGLP-1 Receptor Agonist MechanismTarget Trial...